Sanofi and Regeneron’s immunology blockbuster Dupixent was knocked down into second place as Eli Lilly’s diabetes medicine Trulicity took the top spot for January’s biggest TV ad spenders, according ...
It’s as things were in January for the first two spots of pharma’s top TV ad spenders. In February again, Lilly’s diabetes drug Trulicity came in at No. 1 with a hefty $45.8 million spend, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results